CL2004002061A1 - Compuestos derivados de heterociclos condensados que contienen nitrogeno; composicion farmaceutica; y su uso como agente antiviral, inhubidor de integrasa y como agente anti-vih. - Google Patents
Compuestos derivados de heterociclos condensados que contienen nitrogeno; composicion farmaceutica; y su uso como agente antiviral, inhubidor de integrasa y como agente anti-vih.Info
- Publication number
- CL2004002061A1 CL2004002061A1 CL200402061A CL2004002061A CL2004002061A1 CL 2004002061 A1 CL2004002061 A1 CL 2004002061A1 CL 200402061 A CL200402061 A CL 200402061A CL 2004002061 A CL2004002061 A CL 2004002061A CL 2004002061 A1 CL2004002061 A1 CL 2004002061A1
- Authority
- CL
- Chile
- Prior art keywords
- agent
- hiv
- integrasa
- containing nitrogen
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
LA PRESENTE INVENCION SE REFIERE A UN COMPUESTO DE ANILLO CONDENSADO QUE CONTIENE NITROGENO REPRESENTADO POR LA SIGUIENTE FORMULA [1] EN DONDE CADA SIMBOLO ES TAL COMO SE DEFINIO EN LA MEMORIA DESRIPTIVAO, O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES, Y UN AGENTE ENTI-VIH QUE CONTIENE DICHO COMPUESTO. EL COMPUESTO DE LA PRESENTE INVENCION TIENE UNA ACTIVIDAD INHIBIDORA DE LA INTERGRASA DEL VIH Y ES UTIL COMO AGENTE PARA PROFILAXIS O EL TRATAMIENTO DEL SIDA, O COMO UNA AGENTE ANTI-VIH. ADEMAS, CON EL USO COMBINADO CON OTROS AGENTES ANTI-VIH TAL COMO INHIBIDOR DE LA PROTEASA, UN INHIBIDOR DE LA TRANSCRIPTASA INVERSA Y SIMILARES, PUEDE SER UN AGENTE ANTI-VIH MAS EFECTIVO. COMO PRESENTA UNA ALTA ACTIVIDAD INHIBIDORA ESPECIFICA DE LA INTEGRASA, EL COMPUESTO PUEDE SER UN AGENTE FARMACEUTICAMENTE SEGURO EN EL CUERPO HUMANO, EL CUAL PROVOCA SOLO UNA MENOR CANTIDAD DE EFECTOS COLATERALES.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003293117 | 2003-08-13 | ||
JP2004134896 | 2004-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2004002061A1 true CL2004002061A1 (es) | 2005-06-03 |
Family
ID=34197143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200402061A CL2004002061A1 (es) | 2003-08-13 | 2004-08-13 | Compuestos derivados de heterociclos condensados que contienen nitrogeno; composicion farmaceutica; y su uso como agente antiviral, inhubidor de integrasa y como agente anti-vih. |
Country Status (15)
Country | Link |
---|---|
US (3) | US20050054645A1 (es) |
EP (2) | EP1544199B1 (es) |
JP (1) | JP3814631B2 (es) |
AR (1) | AR045367A1 (es) |
AT (1) | ATE411315T1 (es) |
CA (1) | CA2577239A1 (es) |
CL (1) | CL2004002061A1 (es) |
DE (1) | DE602004017108D1 (es) |
DK (1) | DK1544199T3 (es) |
ES (1) | ES2315700T3 (es) |
PE (1) | PE20050361A1 (es) |
PT (1) | PT1544199E (es) |
SI (1) | SI1544199T1 (es) |
TW (1) | TW200510425A (es) |
WO (1) | WO2005016927A1 (es) |
Families Citing this family (117)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006232849A (ja) * | 2003-08-13 | 2006-09-07 | Japan Tobacco Inc | 含窒素縮合環化合物及びそのhivインテグラーゼ阻害剤としての利用 |
US7517994B2 (en) * | 2003-11-19 | 2009-04-14 | Array Biopharma Inc. | Heterocyclic inhibitors of MEK and methods of use thereof |
US7732616B2 (en) * | 2003-11-19 | 2010-06-08 | Array Biopharma Inc. | Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof |
JP4768628B2 (ja) * | 2003-11-19 | 2011-09-07 | アレイ バイオファーマ、インコーポレイテッド | Mekの二環系阻害剤及びその使用方法 |
US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
JP2007528394A (ja) * | 2004-03-09 | 2007-10-11 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害薬 |
AU2005221864A1 (en) * | 2004-03-09 | 2005-09-22 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | HIV integrase inhibitors |
WO2005086700A2 (en) * | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
US7598264B2 (en) * | 2004-03-09 | 2009-10-06 | Merck & Co., Inc. | HIV integrase inhibitors |
US7115601B2 (en) * | 2004-05-18 | 2006-10-03 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
EP1758581A1 (en) * | 2004-05-21 | 2007-03-07 | Japan Tobacco, Inc. | Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
JP4953297B2 (ja) * | 2004-09-15 | 2012-06-13 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体 |
US7745459B2 (en) * | 2004-09-21 | 2010-06-29 | Japan Tobacco Inc. | Quinolizinone compound and use thereof as HIV integrase inhibitor |
US7858788B2 (en) * | 2005-02-21 | 2010-12-28 | Shionogi & Co., Ltd. | Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
AU2006228278C1 (en) * | 2005-03-31 | 2011-06-23 | Msd Italia S.R.L. | HIV integrase inhibitors |
EA014162B1 (ru) * | 2005-04-28 | 2010-10-29 | Смитклайн Бичем Корпорейшн | Полициклическое карбамоилпиридоновое производное, обладающее ингибиторной активностью в отношении интегразы вич |
US7879797B2 (en) | 2005-05-02 | 2011-02-01 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
JP4982482B2 (ja) | 2005-05-10 | 2012-07-25 | メルク・シャープ・エンド・ドーム・コーポレイション | Hivインテグラ−ゼ阻害剤 |
SG177981A1 (en) * | 2005-05-18 | 2012-02-28 | Array Biopharma Inc | 4-(phenylamino)-6-oxo-1, 6-dihydropyridazine-3-carboxamide derivatives as mek inhibitors for the treatment of hyperproliferative diseases |
JP2006342115A (ja) * | 2005-06-10 | 2006-12-21 | Shionogi & Co Ltd | Hivインテグラーゼ阻害活性を有する多環性化合物 |
EP1906971A2 (en) * | 2005-07-27 | 2008-04-09 | Gilead Sciences, Inc. | Antiviral compounds |
JP4705984B2 (ja) | 2005-08-01 | 2011-06-22 | メルク・シャープ・エンド・ドーム・コーポレイション | Hcvns3プロテアーゼ阻害剤としての大環状ペプチド |
ATE517899T1 (de) * | 2005-10-04 | 2011-08-15 | Angeletti P Ist Richerche Bio | Hiv-integrasehemmer |
AU2006307101A1 (en) | 2005-10-27 | 2007-05-03 | Shionogi & Co., Ltd. | Polycyclic carbamoylpyridone derivative having inhibitory activity on HIV integrase |
WO2007089030A1 (en) * | 2006-02-01 | 2007-08-09 | Japan Tobacco Inc. | Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
GB0609492D0 (en) | 2006-05-15 | 2006-06-21 | Angeletti P Ist Richerche Bio | Therapeutic agents |
WO2007136714A2 (en) | 2006-05-16 | 2007-11-29 | Gilead Sciences, Inc. | Integrase inhibitors |
GB0612423D0 (en) | 2006-06-23 | 2006-08-02 | Angeletti P Ist Richerche Bio | Therapeutic agents |
WO2008048538A1 (en) * | 2006-10-18 | 2008-04-24 | Merck & Co., Inc. | Hiv integrase inhibitors |
CA2667266C (en) | 2006-10-24 | 2015-11-24 | Merck & Co., Inc. | Hcv ns3 protease inhibitors |
EP2079479B1 (en) | 2006-10-24 | 2014-11-26 | Merck Sharp & Dohme Corp. | Hcv ns3 protease inhibitors |
AU2007309546A1 (en) | 2006-10-24 | 2008-05-02 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | HCV NS3 protease inhibitors |
US8377874B2 (en) | 2006-10-27 | 2013-02-19 | Merck Sharp & Dohme Corp. | HCV NS3 protease inhibitors |
US20100099695A1 (en) | 2006-10-27 | 2010-04-22 | Liverton Nigel J | HCV NS3 Protease Inhibitors |
EP2121707B1 (en) | 2006-12-20 | 2012-12-05 | Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. | Antiviral indoles |
GB0625345D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
GB0625349D0 (en) | 2006-12-20 | 2007-01-31 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
AU2007342367B2 (en) | 2007-01-05 | 2012-12-06 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection |
CA2693537C (en) | 2007-07-17 | 2013-06-25 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Macrocyclic indole derivatives for the treatment of hepatitis c infections |
US8927569B2 (en) | 2007-07-19 | 2015-01-06 | Merck Sharp & Dohme Corp. | Macrocyclic compounds as antiviral agents |
WO2009067541A2 (en) * | 2007-11-20 | 2009-05-28 | Gilead Sciences, Inc. | Integrase inhibitors |
CN101977610B (zh) | 2008-01-25 | 2012-05-16 | 奇默里克斯公司 | 治疗病毒感染的方法 |
WO2009134624A1 (en) | 2008-04-28 | 2009-11-05 | Merck & Co., Inc. | Hcv ns3 protease inhibitors |
EP2318406B1 (en) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
DK2310095T3 (da) | 2008-07-22 | 2012-12-10 | Merck Sharp & Dohme | Makrocykliske quinoxalinforbindelser som hcv-ns3-protease-inhibitorer |
WO2010011818A1 (en) * | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
EP2660239B1 (en) | 2008-07-25 | 2016-11-23 | VIIV Healthcare Company | Chemical compounds as synthetic intermediates |
WO2010011819A1 (en) * | 2008-07-25 | 2010-01-28 | Smithkline Beecham Corporation | Chemical compounds |
BRPI0920605A8 (pt) * | 2008-10-06 | 2016-04-26 | Merck Sharp & Dohme | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, método para o tratamento ou profilaxia de infecção pelo hiv ou para o tratamento, profilaxia, ou retardo no início ou progressão da aids em um paciente em necessidade deste. |
CA2744019C (en) | 2008-12-11 | 2017-03-14 | Shionogi & Co., Ltd. | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
PT2376453T (pt) | 2008-12-11 | 2020-01-14 | Shionogi & Co | Processos e intermediários para inibidores carbamoilpiridona da integrase de vih |
WO2010082050A1 (en) | 2009-01-16 | 2010-07-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections |
GB0900914D0 (en) | 2009-01-20 | 2009-03-04 | Angeletti P Ist Richerche Bio | Antiviral agents |
TWI518084B (zh) * | 2009-03-26 | 2016-01-21 | 鹽野義製藥股份有限公司 | 哌喃酮與吡啶酮衍生物之製造方法 |
US8927710B2 (en) | 2009-06-15 | 2015-01-06 | Shionogi & Co., Ltd. | Substituted polycyclic carbamoylpyridone derivative |
US8828930B2 (en) | 2009-07-30 | 2014-09-09 | Merck Sharp & Dohme Corp. | Hepatitis C virus NS3 protease inhibitors |
EA025176B1 (ru) | 2010-01-27 | 2016-11-30 | Вайв Хелткер Компани | Комбинация для лечения вич-инфекции |
AU2011216243B2 (en) | 2010-02-12 | 2015-07-09 | Chimerix, Inc. | Nucleoside phosphonate salts |
EP2540720B1 (en) * | 2010-02-26 | 2015-04-15 | Japan Tobacco, Inc. | 1,3,4,8-tetrahydro-2h-pyrido[1,2-a]pyrazine derivative and use of same as hiv integrase inhibitor |
TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Viiv醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
EP2552915B1 (en) * | 2010-04-01 | 2017-07-19 | Critical Outcome Technologies Inc. | Compounds for the treatment of hiv |
JP5766690B2 (ja) * | 2010-04-12 | 2015-08-19 | 塩野義製薬株式会社 | インテグラーゼ阻害活性を有するピリドン誘導体 |
TWI526421B (zh) | 2010-09-08 | 2016-03-21 | 住友化學股份有限公司 | 製造嗒酮化合物的方法及其中間物 |
SI2620436T1 (en) | 2010-09-24 | 2018-08-31 | Shionogi & Co., Ltd. | A prodrug substituted polycyclic carbamoyl pyridone derivative |
AU2012321762A1 (en) * | 2011-10-12 | 2014-04-17 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase-inhibiting activity |
US9328138B2 (en) | 2011-11-15 | 2016-05-03 | Msd Italia S.R.L. | HCV NS3 protease inhibitors |
WO2014099586A1 (en) * | 2012-12-17 | 2014-06-26 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as hiv integrase inhibitors |
MY191741A (en) | 2012-12-21 | 2022-07-13 | Gilead Sciences Inc | Polycyclic-carbamoylpyridone compounds and their pharmaceutical use |
MX2015008467A (es) * | 2012-12-27 | 2015-09-23 | Japan Tobacco Inc | Derivado sustituido de espiropirido[1,2-a]pirazina y uso medico del mismo como inhibidor de la integrasa del virus de inmunodeficiencia humana. |
WO2014121417A1 (en) | 2013-02-07 | 2014-08-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c |
WO2014121418A1 (en) | 2013-02-07 | 2014-08-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c |
WO2014121416A1 (en) | 2013-02-07 | 2014-08-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c |
US9493479B2 (en) | 2013-04-16 | 2016-11-15 | Merck Sharp & Dohme Corp. | Substituted pyrido[1,2-a]pyrazines as HIV integrase inhibitors |
PL2997033T3 (pl) | 2013-05-17 | 2018-04-30 | Merck Sharp & Dohme Corp. | Skondensowane tricykliczne związki heterocykliczne jako inhibitory integrazy hiv |
US9951079B2 (en) | 2013-06-13 | 2018-04-24 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as HIV integrase inhibitors |
WO2015001572A2 (en) * | 2013-07-04 | 2015-01-08 | Hetero Research Foundation | Process for the preparation of intermediate of dolutegravir |
NO2865735T3 (es) | 2013-07-12 | 2018-07-21 | ||
HUE037347T2 (hu) | 2013-07-12 | 2018-08-28 | Gilead Sciences Inc | Policiklusos karmaboilpiridon vegyületek és alkalmazásuk HIV fertõzések kezelésére |
WO2015038655A1 (en) | 2013-09-12 | 2015-03-19 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
AP2016009157A0 (en) | 2013-09-27 | 2016-04-30 | Merck Sharp & Dohme | Substituted quinolizine derivatives useful as hiv integrase inhibitors |
WO2015089847A1 (en) * | 2013-12-20 | 2015-06-25 | Merck Sharp & Dohme Corp. | Spirocyclic heterocycle compounds useful as hiv integrase inhibitors |
CN114404427A (zh) | 2014-02-13 | 2022-04-29 | 配体药物公司 | 前药化合物及其用途 |
TWI744723B (zh) | 2014-06-20 | 2021-11-01 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
NO2717902T3 (es) | 2014-06-20 | 2018-06-23 | ||
TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
JP2017520545A (ja) | 2014-07-02 | 2017-07-27 | リガンド・ファーマシューティカルズ・インコーポレイテッド | プロドラッグ化合物およびそれらの使用 |
CN107074880A (zh) * | 2014-07-07 | 2017-08-18 | 萨维拉制药有限公司 | 二氢吡啶并吡嗪‑1,8‑二酮和它们在治疗、改善或预防病毒疾病中的用途 |
WO2016005331A1 (en) * | 2014-07-07 | 2016-01-14 | F. Hoffmann-La Roche Ag | Pyridopyrazine compounds and their use in the treatment, amelioration or prevention of influenza |
US10011613B2 (en) | 2014-08-22 | 2018-07-03 | Shionogi & Co., Ltd. | Polycyclic pyridone derivative having integrase inhibitory activity |
WO2016090545A1 (en) | 2014-12-09 | 2016-06-16 | Merck Sharp & Dohme Corp. | Spirocyclic heterocycle compounds useful as hiv integrate inhibitors |
TWI695003B (zh) | 2014-12-23 | 2020-06-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
US10208045B2 (en) | 2015-03-11 | 2019-02-19 | Alios Biopharma, Inc. | Aza-pyridone compounds and uses thereof |
PL3277691T3 (pl) | 2015-04-02 | 2019-07-31 | Gilead Sciences, Inc. | Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne |
CN113004304B (zh) | 2015-04-28 | 2022-03-18 | 盐野义制药株式会社 | 经取代的多环性吡啶酮衍生物及其前药 |
CA2984130C (en) | 2015-04-28 | 2021-07-20 | Shionogi & Co., Ltd. | Substituted polycyclic pyridone derivative and prodrug thereof |
WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
WO2017087257A1 (en) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
US10544155B2 (en) | 2015-12-15 | 2020-01-28 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as HIV integrase inhibitors |
EP3391888B1 (en) | 2015-12-15 | 2023-09-27 | Shionogi & Co., Ltd. | Medicine for treating influenza characterized by comprising combination of cap-dependent endonuclease inhibitor with anti-influenza drug |
WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
CN108699059B (zh) | 2016-03-08 | 2021-06-18 | 诺华股份有限公司 | 可用于治疗正粘病毒感染的三环化合物 |
MA45939A (fr) | 2016-08-10 | 2019-06-19 | Shionogi & Co | Dérivé de pyridone polycyclique substitué et composition pharmaceutique contenant un promédicament de celui-ci |
JOP20170169A1 (ar) | 2016-08-29 | 2019-01-30 | Novartis Ag | مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو |
BR112019011074B1 (pt) | 2016-12-02 | 2021-01-19 | Merck Sharp & Dohme Corp. | Compostos heterocíclicos tricíclicos inibidores de hiv integrase, composição que oscompreende e uso dos mesmos |
JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
EP3573984A4 (en) | 2017-01-26 | 2020-07-29 | Merck Sharp & Dohme Corp. | USEFUL SUBSTITUTE QUINOLIZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS |
US11629149B2 (en) | 2018-02-28 | 2023-04-18 | Novartis Ag | 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1′,2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza |
BR112020021768A2 (pt) * | 2018-04-27 | 2021-01-26 | Merck Sharp & Dohme Corp. | compostos heterocíclicos tricíclicos úteis como inibidores de hiv-integrase |
PE20210477A1 (es) | 2018-05-31 | 2021-03-11 | Shionogi & Co | Derivado policiclico de carbamoilpiridona |
EP3805221A4 (en) | 2018-05-31 | 2022-01-05 | Shionogi & Co., Ltd | POLYCYCLIC PYRIDONE DERIVATIVE |
EP3815689A4 (en) * | 2018-06-27 | 2022-04-20 | National University Corporation Hokkaido University | ARENAVIRUS GROWTH INHIBITOR COMPRISING A POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE |
AU2019339777B2 (en) | 2018-09-12 | 2022-09-01 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
US20200398978A1 (en) | 2019-06-20 | 2020-12-24 | Bell Helicopter Textron Inc. | Low-drag rotor blade extension |
US11667613B2 (en) | 2019-09-26 | 2023-06-06 | Novartis Ag | Antiviral pyrazolopyridinone compounds |
JPWO2021107066A1 (es) | 2019-11-28 | 2021-06-03 | ||
CN116724038A (zh) | 2020-10-21 | 2023-09-08 | 安力高医药股份有限公司 | 双环化合物 |
US11957683B2 (en) | 2021-06-18 | 2024-04-16 | Aligos Therapeutics, Inc. | Bicyclic compounds |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2502281B2 (ja) | 1985-02-25 | 1996-05-29 | キヤノン株式会社 | 情報信号処理装置 |
CA1317298C (en) | 1987-03-03 | 1993-05-04 | Upjohn Company (The) | Antibiotic sulfonylaminocarbonyl activated .beta.-lactams |
JP2993316B2 (ja) * | 1992-05-27 | 1999-12-20 | 宇部興産株式会社 | アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤 |
NO304832B1 (no) * | 1992-05-27 | 1999-02-22 | Ube Industries | Aminokinolonderivater samt middel mot HIV |
TW477787B (en) * | 1996-08-27 | 2002-03-01 | Pfizer | Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same |
US6770666B2 (en) * | 1999-12-27 | 2004-08-03 | Japan Tobacco Inc. | Fused-ring compounds and use thereof as drugs |
AU2001262732A1 (en) | 2000-06-14 | 2001-12-24 | Shionogi And Co., Ltd. | Inhibitor for enzyme having two divalent metal ions as active centers |
JP2004517802A (ja) | 2000-06-16 | 2004-06-17 | ブリストルーマイヤーズ スクイブ カンパニー | Hivインテグラーゼ阻害剤 |
WO2002022574A1 (fr) | 2000-09-11 | 2002-03-21 | Takeda Chemical Industries, Ltd. | Compose tricyclique heterocyclique, son procede de fabrication et son utilisation |
JP2002155084A (ja) * | 2000-09-11 | 2002-05-28 | Takeda Chem Ind Ltd | 3環性複素環化合物、その製造法およびその用途 |
AU1532802A (en) | 2000-10-12 | 2002-04-22 | Merck & Co Inc | Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors |
JP2004517860A (ja) * | 2000-10-12 | 2004-06-17 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 |
JP2004513134A (ja) | 2000-10-12 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルケトン類 |
SK4322003A3 (en) | 2000-10-12 | 2003-09-11 | Merck & Co Inc | Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors |
JP2002293745A (ja) | 2001-03-29 | 2002-10-09 | St Marianna Univ School Of Medicine | 慢性関節リウマチ治療剤 |
AR035543A1 (es) * | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
WO2003016275A1 (en) | 2001-08-10 | 2003-02-27 | Shionogi & Co., Ltd. | Antiviral agent |
WO2003016266A1 (en) | 2001-08-16 | 2003-02-27 | Japan Tobacco Inc. | β-KETOAMIDE COMPOUNDS AND MEDICINAL USE THEREOF |
FR2830863B1 (fr) | 2001-10-12 | 2004-01-30 | Bioalliance Pharma | Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives |
PT1441734E (pt) | 2001-10-26 | 2007-05-31 | Isti Di Ric Di Bio Moleco P An | Di-hidroxipirimidinocarboxamidas inibidoras da integrase do vih |
RS51542B (sr) | 2001-10-26 | 2011-06-30 | Istituto Di Ricerche Di Biologia Molecolare P.Angeletti Spa. | N-supstituisani hidroksipirimidinon karboksamidni inhibitori hiv integraze |
JP4497347B2 (ja) | 2001-12-05 | 2010-07-07 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有する誘導体 |
AU2003216049B2 (en) * | 2002-01-17 | 2008-07-17 | Merck Sharp & Dohme Corp. | Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors |
JP2006506352A (ja) | 2002-09-11 | 2006-02-23 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害剤として有用なジヒドロキシピリドピラジン−1,6−ジオン化合物 |
CA2535451A1 (en) * | 2003-08-13 | 2005-02-24 | Howard J. Smith & Associates Pty Ltd. | Method of treating viral infections |
NL1026826C2 (nl) * | 2003-08-13 | 2007-01-04 | Pharmacia Corp | Gesubstitueerde pyridinonen. |
US7247649B2 (en) * | 2003-08-13 | 2007-07-24 | Hoffmann-La Roche Inc. | Oxazoles, their manufacture and use as pharmaceutical agents |
DE10337191A1 (de) * | 2003-08-13 | 2005-03-17 | Bayer Healthcare Ag | Neue Verwendung von Chinolon-Antibiotika |
JP2007528394A (ja) | 2004-03-09 | 2007-10-11 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害薬 |
AU2005221864A1 (en) | 2004-03-09 | 2005-09-22 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | HIV integrase inhibitors |
WO2005086700A2 (en) | 2004-03-09 | 2005-09-22 | Merck & Co., Inc. | Hiv integrase inhibitors |
US7598264B2 (en) | 2004-03-09 | 2009-10-06 | Merck & Co., Inc. | HIV integrase inhibitors |
GB0417494D0 (en) * | 2004-08-05 | 2004-09-08 | Glaxosmithkline Biolog Sa | Vaccine |
CA2634499A1 (en) | 2004-12-23 | 2006-06-29 | Virochem Pharma Inc. | Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase |
US7858788B2 (en) * | 2005-02-21 | 2010-12-28 | Shionogi & Co., Ltd. | Bicyclic carbamoylpyridone derivative having HIV integrase inhibitory activity |
-
2004
- 2004-08-11 TW TW093124129A patent/TW200510425A/zh unknown
- 2004-08-12 CA CA002577239A patent/CA2577239A1/en not_active Abandoned
- 2004-08-12 JP JP2005513209A patent/JP3814631B2/ja not_active Expired - Fee Related
- 2004-08-12 EP EP04771830A patent/EP1544199B1/en active Active
- 2004-08-12 ES ES04771830T patent/ES2315700T3/es active Active
- 2004-08-12 WO PCT/JP2004/011869 patent/WO2005016927A1/ja active Application Filing
- 2004-08-12 DE DE602004017108T patent/DE602004017108D1/de active Active
- 2004-08-12 EP EP08166109A patent/EP2042502A1/en not_active Withdrawn
- 2004-08-12 PT PT04771830T patent/PT1544199E/pt unknown
- 2004-08-12 AT AT04771830T patent/ATE411315T1/de not_active IP Right Cessation
- 2004-08-12 DK DK04771830T patent/DK1544199T3/da active
- 2004-08-12 SI SI200430973T patent/SI1544199T1/sl unknown
- 2004-08-13 CL CL200402061A patent/CL2004002061A1/es unknown
- 2004-08-13 PE PE2004000787A patent/PE20050361A1/es not_active Application Discontinuation
- 2004-08-13 AR ARP040102913A patent/AR045367A1/es unknown
- 2004-10-05 US US10/958,225 patent/US20050054645A1/en not_active Abandoned
-
2005
- 2005-10-13 US US11/255,605 patent/US7211572B2/en active Active
-
2007
- 2007-04-06 US US11/783,270 patent/US20080161311A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2577239A1 (en) | 2005-02-24 |
EP1544199A1 (en) | 2005-06-22 |
EP2042502A1 (en) | 2009-04-01 |
PT1544199E (pt) | 2008-12-03 |
US20050054645A1 (en) | 2005-03-10 |
US20080161311A1 (en) | 2008-07-03 |
DK1544199T3 (da) | 2009-01-12 |
AR045367A1 (es) | 2005-10-26 |
WO2005016927A1 (ja) | 2005-02-24 |
TW200510425A (en) | 2005-03-16 |
JPWO2005016927A1 (ja) | 2006-10-12 |
JP3814631B2 (ja) | 2006-08-30 |
DE602004017108D1 (de) | 2008-11-27 |
US20060052361A1 (en) | 2006-03-09 |
ATE411315T1 (de) | 2008-10-15 |
US7211572B2 (en) | 2007-05-01 |
SI1544199T1 (sl) | 2009-04-30 |
EP1544199A4 (en) | 2006-07-26 |
ES2315700T3 (es) | 2009-04-01 |
PE20050361A1 (es) | 2005-06-27 |
EP1544199B1 (en) | 2008-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2004002061A1 (es) | Compuestos derivados de heterociclos condensados que contienen nitrogeno; composicion farmaceutica; y su uso como agente antiviral, inhubidor de integrasa y como agente anti-vih. | |
BR0306214A (pt) | Composto de 4-oxoquinolina e uso deste como inibidor de integrase de hiv | |
PA8572201A1 (es) | Inhibidores de metaloproteinasa de triaril-oxi-aril-espiro-pirimidina-2,4,6-triona | |
UY26825A1 (es) | Composción y actividad antiviral de derivados piperazina indoloxoacéticos sustituidos | |
SE0001899D0 (sv) | New compounds | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
HRP20040059B1 (en) | Treatment of nail infections with no | |
IL164490A (en) | Phosphonate analogs of hiv protease inhibitor compounds | |
MXPA04004837A (es) | Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1. | |
HN2001000244A (es) | Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas. | |
MX2022016405A (es) | Análogos de nucleósido de 1¿-ciano y usos de estos. | |
MY144773A (en) | 6-(heterocycle-susbtituted benzyl) -4-oxoquinoline compound and use of the same as hiv integrase inhibitor | |
ES2178048T3 (es) | Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis. | |
BRPI0513051A (pt) | combinação de inibidores de transcriptase reversa e de protease anti-hiv | |
ES2174921T3 (es) | Inhibidores de la proteasa del vih. | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
BRPI0509667A (pt) | azaquinazolinas substituìdas com eficácia antiviral | |
ME00624B (me) | Nova primjena docetaksela za liječenje hepatoma | |
BR0317095A (pt) | Uso de uma combinação contendo um inibidor da transcriptase reversa sem ser de nucleosìdeo (nnrti) com um inibidor citocromo p450, tal como inibidores da protease | |
EP1868613A4 (en) | POLYMORPHOS OF 3-O- (3 ', 3'-DIMETHYLSUCCINYL) BETULINIC DI-N-METHYL-D-GLUCAMINE | |
DE602005023437D1 (de) | Als inhibitor von retroviraler protease geeignete ritonavir-analoge verbindung, herstellung der ritonavir-analogen verbindung und pharmazeutische zusammenetzung für die ritonavir-analoge verbindung | |
PA8549401A1 (es) | Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido | |
BR0312183A (pt) | Uso de compostos benzisosselenazolonas contra lesão miocárdica isquêmica | |
AR013087A1 (es) | Forma v de amprenavir, su uso como compuesto antiviral, un proceso para prepararlo, y composiciones farmaceuticas que lo comprenden | |
WO2020260956A3 (en) | Self-emulsifying cannabidiol formulations |